ProPhase Labs, Inc.
PRPH
$0.416
$0.00852.09%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.75M | 17.97M | 28.72M | 44.38M | 62.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.75M | 17.97M | 28.72M | 44.38M | 62.71M |
| Cost of Revenue | 16.88M | 19.61M | 23.43M | 28.15M | 32.13M |
| Gross Profit | -4.13M | -1.64M | 5.29M | 16.24M | 30.58M |
| SG&A Expenses | 30.48M | 31.07M | 33.80M | 34.50M | 39.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.17M | 51.93M | 59.50M | 66.00M | 78.06M |
| Operating Income | -35.41M | -33.96M | -30.79M | -21.61M | -15.35M |
| Income Before Tax | -38.03M | -35.72M | -32.20M | -22.80M | -16.32M |
| Income Tax Expenses | -10.28M | -9.41M | -8.60M | -6.02M | -5.85M |
| Earnings from Continuing Operations | -27.76 | -26.31 | -23.60 | -16.78 | -10.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.76M | -26.31M | -23.60M | -16.78M | -10.48M |
| EBIT | -35.41M | -33.96M | -30.79M | -21.61M | -15.35M |
| EBITDA | -27.88M | -27.01M | -24.12M | -15.34M | -9.99M |
| EPS Basic | -1.50 | -1.46 | -1.34 | -0.96 | -0.62 |
| Normalized Basic EPS | -1.29 | -1.24 | -1.14 | -0.81 | -0.59 |
| EPS Diluted | -1.52 | -1.47 | -1.35 | -0.96 | -0.62 |
| Normalized Diluted EPS | -1.29 | -1.24 | -1.14 | -0.81 | -0.60 |
| Average Basic Shares Outstanding | 74.07M | 72.16M | 70.12M | 68.82M | 67.01M |
| Average Diluted Shares Outstanding | 74.07M | 72.16M | 70.12M | 70.14M | 68.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -0.02% |
